2021
DOI: 10.1177/01455613211036240
|View full text |Cite
|
Sign up to set email alerts
|

Parathyroid Carcinoma in a Patient With Secondary Hyperparathyroidism and Thyroid Hemiagenesis: A Case Report and Review of the Literature

Abstract: Parathyroid carcinoma is a rare endocrine tumor. Parathyroid carcinoma in patients with secondary hyperparathyroidism due to chronic kidney disease is also rare. In addition, thyroid hemiagenesis is a rare congenital anomaly. We report an extremely rare case of parathyroid carcinoma in a patient with secondary hyperparathyroidism and thyroid hemiagenesis. We also present a review of the literature of this rare entity. We also discuss the surgical procedure performed for this patient. Our review of the literatu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…Few over 1100 cases of parathyroid malignancy have been reported worldwide [ 4 ], the majority (97%) associated with primary hyperparathyroidism (PHPT) [ 5 ]. Parathyroid neoplasia is quite uncommon in patients with secondary or tertiary hyperparathyroidism, only 34 cases being reported in the literature associated with end stage renal disease [ 6 ], Table 1 . Considering gender distribution, both men and women are equally affected, in contrast to benign parathyroid tumors that occur more frequently in women (male:female ratio is 1:4) [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Few over 1100 cases of parathyroid malignancy have been reported worldwide [ 4 ], the majority (97%) associated with primary hyperparathyroidism (PHPT) [ 5 ]. Parathyroid neoplasia is quite uncommon in patients with secondary or tertiary hyperparathyroidism, only 34 cases being reported in the literature associated with end stage renal disease [ 6 ], Table 1 . Considering gender distribution, both men and women are equally affected, in contrast to benign parathyroid tumors that occur more frequently in women (male:female ratio is 1:4) [ 7 ].…”
Section: Introductionmentioning
confidence: 99%